Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2022 07:00 ET | Source: Ikena Oncology

Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

Over $140M in capital raised in initial public offering in 2021; Cash runway through first half 2024 Advanced IK-930, lead targeted oncology program, into the clinic, continuing leadership in the...
March 01, 2022 07:00 ET | Source: Ikena Oncology

Ikena Oncology to Participate in Cowen 42nd Annual Health Care Conference

BOSTON, March 01, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company navigating new territory in patient-directed cancer treatment, today announced that...
January 26, 2022 07:00 ET | Source: Ikena Oncology

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors

BOSTON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company navigating new territory in patient-directed cancer treatment, today announced the...